Panel Discussion | Considerations for TAV in TAV versus Explant

Sunday, March 9, 2025

10:49 AM - 11:15 AM ET

Panel Moderator(s)

Aaron Horne, Jr., MD, MBA

Structural Interventionalist
Summit Health
Berkeley Heights, New Jersey, United States

No relationships to disclose
Jaffar M. Khan, MD, PhD

Director of Cardiovascular Innovation and Director of Interventional Electrosurgery
St Francis Hospital and Heart Center
Roslyn, New York, United States

No relationships to disclose
Gilbert H L Tang, MD, MSc, MBA

Surgical Director, Structural Heart Program
Mount Sinai Health System
New York, New York, United States

No relationships to disclose

Panel Discussant(s)

Keith B. Allen, MD

Director of Surgical Research and Surgical Director of Structural Heart, St. Luke’s Hospital, Kansas City, MO
St. Luke's Mid America Heart Institute
Shawnee, Kansas, United States

Disclosure information not submitted.
Adnan Chhatriwalla, MD

Medical Director, Structural Intervention
Saint Luke's Mid America Heart Institute
Kansas City, Missouri, United States

No relationships to disclose
Sundar Chidambaram, MD DNB DM FNB

CONSULTANT INTERVENTIONAL CARDIOLOGIST AND ENDOVASCULAR. SPECIALIST
KAUVERY HOSPITAL, Tamil Nadu, India

No relationships to disclose
Kalyan R. Chitturi, DO

Interventional Cardiologist
Houston Cardiovascular Associates
The Woodlands, Texas, United States

No relationships to disclose
Omar Khalique, MD

Director, Division of Cardiovascular Imaging
St. Francis Hospital and Catholic Health, United States

Disclosure(s): Edwards Lifesciences: Consultant (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Heartflow, Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consultant (Ongoing); Siemens: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Jean-Michel Paradis, MD

Structural and Interventional Cardiologist
Quebec Heart and Lung Institute
Quebec, Quebec, Canada

No relationships to disclose
Stephanie Sellers, PhD

Assistant Professor
University of British Columbia
Vancouver, British Columbia, Canada

No relationships to disclose

Disclosure(s):

Aaron Horne, MD, MBA, Jr.: Zoll Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jaffar M. Khan, MD, PhD: Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Cuspa medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Gilbert H L Tang, MD, MSc, MBA: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Terminated); Peijia: Consultant (Ongoing); shenqi Medical Technology: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical Inc: Consultant (Ongoing)

Keith B. Allen, MD: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Adnan Chhatriwalla, MD: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic Inc: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Rogers Towers: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 10, 2025)

Sundar Chidambaram, MD DNB DM FNB: No financial relationships to disclose

Omar Khalique, MD: Edwards Lifesciences: Consultant (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Heartflow, Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consultant (Ongoing); Siemens: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jean-Michel Paradis, MD: Boston Scientific: Consulting Fees (e.g., advisory boards) (Terminated); Edwards Lifesciences LLC: Consultant (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

Stephanie Sellers, PhD: Abbott: Consultant (Ongoing); Anteris: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Excision Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock options (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Vivitro Labs: Grant/Research Support (Ongoing)